CompletedEarly Phase 1NCT02998151

Neurophysiological and Acute Pharmacological Studies in FXS Patients

Studying Fragile X syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Children's Hospital Medical Center, Cincinnati
Principal Investigator
Craig A Erickson, M.D.
Children's Hospital Medical Center, Cincinnati
Intervention
Acamprosate(drug)
Enrollment
29 enrolled
Eligibility
15-55 years · All sexes
Timeline
20162020

Study locations (1)

Collaborators

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02998151 on ClinicalTrials.gov

Other trials for Fragile X syndrome

Additional recruiting or active studies for the same condition.

See all trials for Fragile X syndrome

← Back to all trials